주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
210 )
기사목록 보기 형태
제목형
요약형
포토형
[Interview] Tagrisso offers a new option for 1st-line treatment of stage 4 lung cancer
Kim Yun-mi Korea Biomedical Review correspondent
2023.09.13 13:17
‘Improve clinical trial regulations to raise success rate of homegrown drugs’
Kim Yun-mi Korea Biomedical Review correspondent
2023.09.12 14:52
Professor Ahn Myung-ju wins Distinguished Service Award at WCLC 2023
Kim Yun-mi
2023.09.11 11:42
Patients call for speeding up coverage of neurofibromatosis drug Koselugo
Kim Yun-mi
2023.09.06 11:42
‘Socioeconomic benefit of Enhertu estimated to be ₩260 bil.’
Kim Yun-mi
2023.09.05 10:43
‘Many Korean women still use contraceptive methods highly likely to fail’
Kim Yun-mi
2023.09.04 16:00
Will Jakavi’s added evidence for PV cure lead to reimbursement in Korea?
Kim Yun-mi
2023.08.25 14:11
‘Tecvayli goes beyond conventional multiple myeloma treatment concepts’
Kim Yun-mi
2023.08.24 15:21
Reimbursement for 1st fast-track drug Koselugo ‘under discussion’ for 2 years
Kim Yun-mi
2023.08.22 13:41
Patients get antsy amid protracted price bargaining for Spinraza, Evrysdi
Kim Yun-mi
2023.08.21 16:31
MSD picks boy group Seventeen as global ambassador for HPV prevention
Kim Yun-mi
2023.08.17 13:50
MSD Korea applies for reimbursing all 13 indications of Keytruda. Will it lead to a new coverage model?
Kim Yun-mi
2023.08.11 13:59
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기